Cann Group Stock

Cann Group EBIT 2024

Cann Group EBIT

-25.35 M AUD

Ticker

CAN.AX

ISIN

AU000000CAN2

WKN

A2DSUQ

In 2024, Cann Group's EBIT was -25.35 M AUD, a -17.23% increase from the -30.63 M AUD EBIT recorded in the previous year.

The Cann Group EBIT history

YEAREBIT (undefined AUD)
2025e-
2024-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-

Cann Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Cann Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cann Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cann Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cann Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cann Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cann Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cann Group’s growth potential.

Cann Group Revenue, EBIT and net profit per share

DateCann Group RevenueCann Group EBITCann Group Net Income
2025e504.78 M AUD0 AUD0 AUD
202417.52 M AUD-25.35 M AUD-51.24 M AUD
202313.78 M AUD-30.63 M AUD-33.79 M AUD
20226.41 M AUD-24.55 M AUD-26.47 M AUD
20214.33 M AUD-23.46 M AUD-25.1 M AUD
2020910,580 AUD-15.44 M AUD-16.94 M AUD
20192.35 M AUD-11.91 M AUD-10.93 M AUD
2018560,000 AUD-5.77 M AUD-4.73 M AUD
20170 AUD-2.6 M AUD-2.59 M AUD
20160 AUD-1.45 M AUD-1.46 M AUD
20150 AUD0 AUD0 AUD

Cann Group stock margins

The Cann Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cann Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cann Group.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cann Group's sales revenue. A higher gross margin percentage indicates that the Cann Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cann Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cann Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cann Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cann Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cann Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cann Group Margin History

Cann Group Gross marginCann Group Profit marginCann Group EBIT marginCann Group Profit margin
2025e30.5 %0 %0 %
202430.5 %-144.67 %-292.43 %
202330.5 %-222.31 %-245.26 %
202230.5 %-383 %-412.85 %
202130.5 %-541.21 %-579.21 %
202030.5 %-1,695.85 %-1,860.07 %
201930.5 %-507.26 %-465.41 %
2018410.2 %-1,029.59 %-843.9 %
201730.5 %0 %0 %
201630.5 %0 %0 %
201530.5 %0 %0 %

Cann Group Aktienanalyse

What does Cann Group do?

Cann Group Ltd is an Australian company specializing in the production and marketing of medical cannabis. The company was founded in 2013 and is headquartered in Melbourne. The company's history began with the founding of an independent consulting firm called AusCann Group Holdings Ltd in 2014. This firm was created to inform Australian and international investors about the opportunities and possibilities in the Australian cannabis market. In 2016, a cooperation agreement was signed between AusCann and Cann Group Ltd to advance the cultivation and production of medical cannabis products in Australia. Since then, Cann Group has continuously invested in the development and growth of the Australian medical cannabis market. The company has obtained a Good Manufacturing Practices (GMP) compliance license to ensure that all products meet the highest quality and safety standards. This includes collaborating with research institutions and state health authorities to investigate the efficacy and safety of medications. Cann Group's various business areas include the production of medical cannabis, research, product development, and marketing. The company operates a cannabis cultivation facility in Cochranes Hill, Victoria, covering an area of 20 hectares. The cultivation of cannabis is carried out under controlled conditions to ensure that all products are of the highest quality and purity. The cultivated cannabis is then used to manufacture medical products such as oils, tinctures, capsules, and sprays. Cann Group also collaborates closely with research institutions and academic institutions to study the safety and efficacy of medical cannabis. The company has partnerships with the University of Melbourne, Queensland University of Technology, and Swinburne University of Technology for research on the mechanisms of cannabis, application research, and studies on the clinical efficacy of cannabis. The business model of Cann Group is based on the sale of medical cannabis products to pharmacies and medical facilities in Australia and worldwide. The company, through its license, is one of the few companies capable of producing and exporting medical cannabis for the Australian market. In addition to exporting cannabis products to Germany, New Zealand, the UK, and other countries, the sale of cannabis products to the Australian market is the largest market for Cann Group. The company offers a variety of medical cannabis products specifically developed for various medical conditions. These include products for anxiety, nausea and vomiting, pain, seizures, and many other diseases. There are also products for palliative care, which help alleviate pain and suffering in the final stages. Overall, Cann Group Ltd has played a pioneering role in the development of the Australian medical cannabis market in recent years. The company specializes in the production of medical cannabis products that meet the highest quality standards and strict regulatory requirements. The company is committed to improving the therapeutic approach to diseases and enhancing the quality of life for patients. Cann Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Cann Group's EBIT

Cann Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cann Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cann Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cann Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cann Group stock

How much did Cann Group achieve in EBIT for the current year?

In the current year, Cann Group has achieved an EBIT of -25.35 M AUD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Cann Group.

How has the EBIT of Cann Group developed in recent years?

The EBIT of Cann Group has increased by -17.229% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Cann Group?

The EBIT of Cann Group is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Cann Group pay?

Over the past 12 months, Cann Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cann Group is expected to pay a dividend of 0 AUD.

What is the dividend yield of Cann Group?

The current dividend yield of Cann Group is .

When does Cann Group pay dividends?

Cann Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cann Group?

Cann Group paid dividends every year for the past 0 years.

What is the dividend of Cann Group?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cann Group located?

Cann Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cann Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cann Group from 11/30/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/30/2024.

When did Cann Group pay the last dividend?

The last dividend was paid out on 11/30/2024.

What was the dividend of Cann Group in the year 2023?

In the year 2023, Cann Group distributed 0 AUD as dividends.

In which currency does Cann Group pay out the dividend?

The dividends of Cann Group are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cann Group

Our stock analysis for Cann Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cann Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.